Effect of losartan on plasma adiponectin in patients with end stage renal disease

Phase 3

• Conditions: End-stage renal disease (ESRD).; ESRD on hemodialysis; N 18.6

• Registration Number: IRCT2013112515535N1
• Lead Sponsor: Vice chancellor for research, Shahrekord University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 73

Inclusion Criteria

Patients with ESRD; non-diabetice; normotensive; weekly schedule of dialysis.

Exclusion criteria: Hypotension; hyperkalemia

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adiponectin change. Timepoint: Initial and after 4 months. Method of measurement: ELISA Assay with Adiponectin Kit.

Secondary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: Dialysis time. Method of measurement: Blood pressure meter.;Potassium. Timepoint: Weekly. Method of measurement: Labratory.